BIOMAT Database Logo BIOMAT Database Logo

Intracellular carbovir triphosphate levels in patients taking abacavir once a day. 2002

Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D003848 Deoxyguanine Nucleotides Guanine nucleotides which contain deoxyribose as the sugar moiety. Deoxyguanosine Phosphates,Nucleotides, Deoxyguanine,Phosphates, Deoxyguanosine
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.
April 2009, Antimicrobial agents and chemotherapy,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens.
August 2005, Journal of acquired immune deficiency syndromes (1999),
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Synthesis of carbovir and abacavir from a carbocyclic precursor.
July 2006, Current protocols in nucleic acid chemistry,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.
January 2012, Antiviral therapy,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients.
January 2002, Antimicrobial agents and chemotherapy,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5'-triphosphate metabolite levels.
August 2004, FEBS letters,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitation.
August 2010, Journal of clinical pharmacology,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
September 2001, Antiviral chemistry & chemotherapy,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC-MS/MS.
May 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Marianne Harris, and David Back, and Sean Kewn, and Salima Jutha, and Raymond Marina, and Julio S G Montaner
Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS.
May 2018, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!